Works matching IS 00302414 AND DT 2024 AND VI 102 AND IP 6


Results: 16
    1

    Front & Back Matter.

    Published in:
    Oncology, 2024, v. 102, n. 6, p. 1, doi. 10.1159/000539660
    Publication type:
    Article
    2

    Erratum.

    Published in:
    2024
    Publication type:
    Correction Notice
    3

    Erratum.

    Published in:
    2024
    Publication type:
    Correction Notice
    4

    Erratum.

    Published in:
    2024
    Publication type:
    Correction Notice
    5
    6
    7
    8

    Clinical Impact of Early Tumour Shrinkage in Metastatic or Unresectable Oesophageal Cancer Treated with Pembrolizumab plus Chemotherapy.

    Published in:
    Oncology, 2024, v. 102, n. 6, p. 484, doi. 10.1159/000535186
    By:
    • Sugase, Takahito;
    • Kanemura, Takashi;
    • Takeoka, Tomohira;
    • Matsuura, Norihiro;
    • Masuike, Yasunori;
    • Shinno, Naoki;
    • Hara, Hisashi;
    • Omori, Takeshi;
    • Kitakaze, Masatoshi;
    • Kubo, Masahiko;
    • Mukai, Yosuke;
    • Sueda, Toshinori;
    • Hasegawa, Shinichiro;
    • Akita, Hirofumi;
    • Nishimura, Junichi;
    • Wada, Hiroshi;
    • Yasui, Masayoshi;
    • Miyata, Hiroshi
    Publication type:
    Article
    9
    10
    11
    12

    Predicting Objective Response of Pembrolizumab in Platinum-Refractory Urothelial Carcinoma Based on Neutrophil-Lymphocyte Ratio Fluctuation and Liver Metastases.

    Published in:
    Oncology, 2024, v. 102, n. 6, p. 457, doi. 10.1159/000534554
    By:
    • Nishio, Kyosuke;
    • Higashio, Takuya;
    • Komura, Kazumasa;
    • Fukuokaya, Wataru;
    • Adachi, Takahiro;
    • Hirasawa, Yosuke;
    • Hashimoto, Takeshi;
    • Yoshizawa, Atsuhiko;
    • Tsuchida, Shuya;
    • Matsuda, Takuya;
    • Tsujino, Takuya;
    • Nishimura, Kazuki;
    • Tokushige, Satoshi;
    • Nakamori, Keita;
    • Uchimoto, Taizo;
    • Yamamoto, Shutaro;
    • Iwatani, Kosuke;
    • Urabe, Fumihiko;
    • Mori, Keiichiro;
    • Yanagisawa, Takafumi
    Publication type:
    Article
    14
    15

    Impact of Tumor Shrinkage Pattern with Biweekly Triplet Gemcitabine+Cisplatin+S-1 Regimen for Biliary Tract Cancers: Implications for Neoadjuvant Therapy from the Data of KHBO1401 (KHBO1401-1A Study).

    Published in:
    Oncology, 2024, v. 102, n. 6, p. 447, doi. 10.1159/000533669
    By:
    • Kobayashi, Shogo;
    • Wada, Hiroshi;
    • Sakai, Daisuke;
    • Baba, Hideo;
    • Kanai, Masashi;
    • Kamachi, Hirofumi;
    • Takayama, Tadatoshi;
    • Ueno, Masaki;
    • Takahashi, Masahiro;
    • Sho, Masayuki;
    • Yoshimura, Kenichi;
    • Hatano, Etsuro;
    • Nagano, Hiroaki;
    • Ioka, Tatsuya
    Publication type:
    Article
    16